ANVS (biotech) - December 2024
ANVS is a clinical-stage biotech company, working on a drug for Alzheimer's Disease (AD). I believe in their approach toward AD, compared to all the other companies that are trying to remove amyloid plaques, which doesn't help fight AD. Check out annovisbio.com/our-science for more of the scientific stuff.
Suffice to say, I believe in the science behind these guys so I think they are safe from going to 0 in the immediate future. That's about as good as you can hope, from a clinical-stage biotech!
For the immediate future, and I'm just talking this month December 2024, I think it could have a strong return this month. Watch the 34-period ema in 65-minute chart (you can use 60-minute chart if you do not have a paid plan, as an approximation).
Current price $7.28, at market close on first day of December (+8.5% today).
Suffice to say, I believe in the science behind these guys so I think they are safe from going to 0 in the immediate future. That's about as good as you can hope, from a clinical-stage biotech!
For the immediate future, and I'm just talking this month December 2024, I think it could have a strong return this month. Watch the 34-period ema in 65-minute chart (you can use 60-minute chart if you do not have a paid plan, as an approximation).
Current price $7.28, at market close on first day of December (+8.5% today).
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.